Sertraline versus imipramine to prevent relapse in chronic depression
Martin B. Keller, Robert H. Howland(University of Pittsburgh), Lisa M. LaVange(University of North Carolina at Chapel Hill), Daniel N. Klein(Stony Brook University), Charles DeBattista, Alan F. Schatzberg(Stanford University), Richard A. Friedman(National Heart Lung and Blood Institute), Susan G. Kornstein(Virginia Commonwealth University), Michael E. Thase(Veterans Health Administration), Alan J. Gelenberg(University of Arizona), James H. Kocsis(Cornell University), A. John Rush(The University of Texas Southwestern Medical Center), Robert M. A. Hirschfeld(The University of Texas Medical Branch at Galveston)
Cited by 66
Related Papers
The 16-Item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression
|Biological Psychiatry|2003|3.9k
Lifetime and 12-Month Prevalence of Bipolar Spectrum Disorder in the National Comorbidity Survey Replication
|Archives of General Psychiatry|2007|2.4k
Resting-state connectivity biomarkers define neurophysiological subtypes of depression
|Nature Medicine|2016|2.2k
Major depressive disorder
|Nature Reviews Disease Primers|2016|2.1k
A Comparison of Nefazodone, the Cognitive Behavioral-Analysis System of Psychotherapy, and Their Combination for the Treatment of Chronic Depression
|New England Journal of Medicine|2000|1.3k